Logo image of EMO

CLEARBRIDGE ENERGY MIDSTREAM (EMO) Stock Overview

NYSE:EMO - US18469P2092

48.7 USD
+0.32 (+0.66%)
Last: 8/29/2025, 8:18:29 PM
Fundamental Rating

2

Taking everything into account, EMO scores 2 out of 10 in our fundamental rating. EMO was compared to 0 industry peers in the Unkown industry. EMO has a bad profitability rating. Also its financial health evaluation is rather negative. EMO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year EMO was profitable.
EMO had a positive operating cash flow in the past year.
Of the past 5 years EMO 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: EMO reported negative operating cash flow in multiple years.
EMO Yearly Net Income VS EBIT VS OCF VS FCFEMO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

Industry RankSector Rank
ROA 10.43%
ROE 14.6%
ROIC N/A
ROA(3y)17.21%
ROA(5y)-5.19%
ROE(3y)24.56%
ROE(5y)-6.89%
ROIC(3y)N/A
ROIC(5y)N/A
EMO Yearly ROA, ROE, ROICEMO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

In the last couple of years the Profit Margin of EMO has declined.
EMO does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 603.29%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-11.55%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMO Yearly Profit, Operating, Gross MarginsEMO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K -4K -6K

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, EMO has more shares outstanding
The number of shares outstanding for EMO has been increased compared to 5 years ago.
EMO has a better debt/assets ratio than last year.
EMO Yearly Shares OutstandingEMO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EMO Yearly Total Debt VS Total AssetsEMO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

Based on the Altman-Z score of 1.44, we must say that EMO is in the distress zone and has some risk of bankruptcy.
The Debt to FCF ratio of EMO is 0.98, which is an excellent value as it means it would take EMO, only 0.98 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.33 indicates that EMO is not too dependend on debt financing.
Even though the debt/equity ratio score it not favorable for EMO, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 0.98
Altman-Z 1.44
ROIC/WACCN/A
WACCN/A
EMO Yearly LT Debt VS Equity VS FCFEMO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.16 indicates that EMO should not have too much problems paying its short term obligations.
A Quick Ratio of 1.16 indicates that EMO should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
EMO Yearly Current Assets VS Current LiabilitesEMO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

EMO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -69.88%.
EMO shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.58% yearly.
Looking at the last year, EMO shows a very strong growth in Revenue. The Revenue has grown by 67.73%.
EMO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.84% yearly.
EPS 1Y (TTM)-69.88%
EPS 3Y14.58%
EPS 5YN/A
EPS Q2Q%-160.09%
Revenue 1Y (TTM)67.73%
Revenue growth 3Y43.68%
Revenue growth 5Y2.84%
Sales Q2Q%131.79%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMO Yearly Revenue VS EstimatesEMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.89 indicates a reasonable valuation of EMO.
When comparing the Price/Earnings ratio of EMO to the average of the S&P500 Index (27.08), we can say EMO is valued rather cheaply.
Industry RankSector Rank
PE 10.89
Fwd PE N/A
EMO Price Earnings VS Forward Price EarningsEMO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 2.91
EV/EBITDA N/A
EMO Per share dataEMO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 8.95%, EMO is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.34, EMO pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.95%

5.2 History

The dividend of EMO decreases each year by -14.22%.
EMO has paid a dividend for at least 10 years, which is a reliable track record.
EMO has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-14.22%
Div Incr Years3
Div Non Decr Years3
EMO Yearly Dividends per shareEMO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

5.3 Sustainability

40.15% of the earnings are spent on dividend by EMO. This is a bit on the high side, but may be sustainable.
DP40.15%
EPS Next 2YN/A
EPS Next 3YN/A
EMO Yearly Income VS Free CF VS DividendEMO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
EMO Dividend Payout.EMO Dividend Payout, showing the Payout Ratio.EMO Dividend Payout.PayoutRetained Earnings

More info and screens

CLEARBRIDGE ENERGY MIDSTREAM

NYSE:EMO (8/29/2025, 8:18:29 PM)

48.7

+0.32 (+0.66%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)07-28 2025-07-28
Earnings (Next)01-26 2026-01-26
Inst Owners29.97%
Inst Owner Change-3.82%
Ins Owners0%
Ins Owner Change0.95%
Market Cap885.85M
Analysts0
Price TargetN/A
Short Float %0.49%
Short Ratio1.68
Dividend
Industry RankSector Rank
Dividend Yield 8.95%
Yearly Dividend2.14
Dividend Growth(5Y)-14.22%
DP40.15%
Div Incr Years3
Div Non Decr Years3
Ex-Date11-20 2025-11-20 (0.36)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.89
Fwd PE N/A
P/S 40.49
P/FCF 2.91
P/OCF 2.91
P/B 0.98
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)4.47
EY9.18%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)16.71
FCFY34.32%
OCF(TTM)16.71
OCFY34.32%
SpS1.2
BVpS49.7
TBVpS49.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.43%
ROE 14.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 603.29%
GM N/A
FCFM 1389.4%
ROA(3y)17.21%
ROA(5y)-5.19%
ROE(3y)24.56%
ROE(5y)-6.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-11.55%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 0.98
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 230.3%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.44
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-69.88%
EPS 3Y14.58%
EPS 5YN/A
EPS Q2Q%-160.09%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)67.73%
Revenue growth 3Y43.68%
Revenue growth 5Y2.84%
Sales Q2Q%131.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y877.49%
FCF growth 3YN/A
FCF growth 5Y26.17%
OCF growth 1Y877.49%
OCF growth 3YN/A
OCF growth 5Y26.17%